AbbVie (ABBV) Raises Dividend 5.2%: Yield and Share Math
Pharmaceutical giant AbbVie (NYSE: ABBV) announced a 5.2% dividend increase, supported by year-to-date equity gains of 28% and a recent earnings report featuring 10% year-over-year revenue growth. Investors evaluating income generation must weigh the current 2.42% dividend yield against broader macroeconomic headwinds.
If maintains its 2.42% yield alongside a 5.2% payout expansion, watch income-focused portfolios because pharmaceutical cash flows offer defensive positioning against broader market pullbacks.